Efflux-Mediated Resistance in Enterobacteriaceae: Recent Advances and Ongoing Challenges to Inhibit Bacterial Efflux Pumps
Antibiotics · 01.08.2025 · 14 (8) · 778
DOI: 10.3390/antibiotics14080778 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antibiotics, online erschienen am 01.08.2025. Verfasst von Florent Rouvier und 3 weiteren Autor:innen. Beteiligte Einrichtung: INSERM, SSA, Aix-Marseille University, MCT, Faculty of Pharmacy, 13385 Marseille, France. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Efflux is one of the key mechanisms used by Gram-negative bacteria to reduce internal antibiotic concentrations. These active transport systems recognize and expel a wide range of toxic molecules, including antibiotics, thereby contributing to reduced antibiotic susceptibility and allowing the bacteria to acquire additional resistance mechanisms. To date, unlike other resistance mechanisms such as enzymatic modification or target mutations/masking, efflux is challenging to detect and counteract in clinical settings, and no standardized methods are currently available to diagnose or inhibit this mechanism effectively. This review first outlines the structural and functional features of major efflux pumps in Gram-negative bacteria and their role in antibiotic resistance. It then explores various strategies used to curb their activity, with a particular focus on efflux pump inhibitors under development, detailing their structural classes, modes of action, and pharmacological potential. We discuss the main obstacles to their development, including the structural complexity and substrate promiscuity of efflux mechanisms, the limitations of current screening methods, pharmacokinetic and tissue distribution issues, and the risk of off-target toxicity. Overcoming these multifactorial barriers is essential to the rational development of less efflux-prone antibiotics or of efflux pump inhibitors.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- INSERM, SSA, Aix-Marseille University, MCT, Faculty of Pharmacy, 13385 Marseille, France.
ORCID-Profile: Jean-Michel Brunel, Jean-Marie Pagès, Julia Vergalli
Zitieren
APA
Rouvier, F., Brunel, J. M., Pagès, J. M., & Vergalli, J. (2025). Efflux-Mediated Resistance in Enterobacteriaceae: Recent Advances and Ongoing Challenges to Inhibit Bacterial Efflux Pumps. Antibiotics, 14(8), 778. https://doi.org/10.3390/antibiotics14080778
Vancouver
Rouvier F, Brunel JM, Pagès JM, Vergalli J. Efflux-Mediated Resistance in Enterobacteriaceae: Recent Advances and Ongoing Challenges to Inhibit Bacterial Efflux Pumps. Antibiotics. 2025;14(8):778. doi:10.3390/antibiotics14080778
BibTeX
@article{Rouvier2025,
author = {Rouvier, Florent and Brunel, Jean-Michel and Pagès, Jean-Marie and Vergalli, Julia},
title = {Efflux-Mediated Resistance in Enterobacteriaceae: Recent Advances and Ongoing Challenges to Inhibit Bacterial Efflux Pumps},
journal = {Antibiotics},
year = {2025},
volume = {14},
number = {8},
pages = {778},
doi = {10.3390/antibiotics14080778}
}
EUVIMED